This gene signature includes genes that are downregulated upon EGFR inhibition of non-small cell lung cancer (NSCLC) cells [32]; thus, EMP3 control cells can be presumed to have an intact EGFR function, as these cells retain the expression of genes that are negatively affected by EGFR inhibition. The gene discussed is EMP3; the disease is non-small cell lung carcinoma.